Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.57 |
| ▸ | EP300 | Q09472 | 2/20 | 0.55 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.55 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.42 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.38 |
| ▸ | NEK2 | P51955 | 1/20 | 0.38 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.38 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.38 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.35 |
| ▸ | CRHBP | P24387 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4083545 | 0.88 | ALDH1A1 (0.52) | IDO1EP300KAT8ALDH1A1CYP3A4 | |
| SCHEMBL27699096 | 0.80 | IDO1 (0.62) | IDO1EP300KAT8HDAC3KAT2B | |
| SCHEMBL4687323 | 0.76 | IDO1 (0.68) | IDO1EP300KAT8HDAC3KAT2B | |
| SCHEMBL13992015 | 0.76 | EPHX2 (0.36) | ALDH1A1EPHX2L3MBTL1KIF11KDM4E | |
| SCHEMBL15537453 | 0.76 | PKM (0.45) | EPHX2MAPTL3MBTL1KIF11KDM4E | |
| SCHEMBL16852474 | 0.76 | CYP1A2 (0.52) | IDO1EP300KAT8ALDH1A1TSHR | |
| SCHEMBL27526979 | 0.76 | EPHX2 (0.39) | IDO1EP300KAT8ALDH1A1TDP1 | |
| SCHEMBL31179075 | 0.75 | HSP90AA1 (0.51) | IDO1EP300KAT8ALDH1A1CYP3A4 | |
| SCHEMBL29893374 | 0.74 | ALDH1A1 (0.50) | ALDH1A1CYP3A4TDP1CRHBPCRHR2 | |
| SCHEMBL112134 | 0.74 | ALDH1A1 (0.50) | ALDH1A1CYP3A4TDP1CRHBPCRHR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7482339-B2 | 2-Naphthylimino-1,3-thiazine derivative | SHIONOGI AND CO., LTD. (JP) | 2009-01-27 | — | — | US | disclosed |
| US-20060281738-A1 | 2-Naphthylimino-1,3-thiazine derivative | SHIONOGI AND CO., LTD. (JP) | 2006-12-14 | — | — | US | disclosed |
| EP-1659117-A1 | 2-NAPHTHYLIMINO-1,3-THIAZINE DERIVATIVE | SHIONOGI & CO., LTD. (JP) | 2006-05-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060281738-A1 | 2-Naphthylimino-1,3-thiazine derivative | NPM1, OXTR, CYP2S1 | IDO1 600/4885EP300 1212/4885KAT8 2260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.